|
Originally published In Press as doi:10.1074/jbc.M403469200 on May 5, 2004
J. Biol. Chem., Vol. 279, Issue 29, 30546-30553, July 16, 2004
Lysine 311 of Protein Geranylgeranyltransferase Type I Partially Replaces Magnesium*
Heather L. Hartman,
Katherine E. Bowers , and
Carol A. Fierke
From the
Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109-1055
Protein geranylgeranyltransferase type I (GGTase I) catalyzes the attachment of a geranylgeranyl lipid group near the carboxyl terminus of protein substrates. Unlike protein farnesyltransferase (FTase) and protein geranylgeranyltransferase type II, which require both Zn(II) and Mg(II) for maximal turnover, GGTase I turnover is dependent only on Zn(II). In FTase, the magnesium ion is coordinated by aspartate 352 and the diphosphate of farnesyl diphosphate to stabilize the developing charge in the transition state (Pickett, J. S., Bowers, K. E., and Fierke, C. A. (2003) J. Biol. Chem. 278, 5124351250). In GGTase I, lysine 311 is substituted for this aspartate and is proposed to replace the catalytic function of Mg(II) (Taylor, J. S., Reid, T. S., Terry, K. L., Casey, P. J., and Beese, L. S. (2003) EMBO J. 22, 59635974). Here we demonstrate that the prenylation rate constant catalyzed by wild type GGTase I (kchem = 0.18 ± 0.02 s-1) is not dependent on Mg(II), is 20-fold slower than the maximal rate constant catalyzed by FTase, and has a single pKa of 6.4 ± 0.1, likely reflecting deprotonation of the peptide thiol. Mutation of lysine 311 in GGTase I to alanine (K 311A) or aspartate (K 311D) decreases the kchem in the absence of magnesium 941-fold without significantly affecting the binding affinity of either substrate. Furthermore, the geranylgeranylation rate constant is enhanced by the addition of Mg(II) for K 311A and K 311D GGTase I 25-fold compared with wild type GGTase I with KMg of 140 ± 10 mM and 6.4 ± 0.8 mM, respectively. These results demonstrate that lysine 311 of GGTase I partially replaces the catalytic function of Mg(II) observed in FTase.
Received for publication, March 29, 2004
, and in revised form, May 5, 2004.
* This work was supported by National Institutes of Health Grant GM40602 (to C. A. F.). Partial funding was also provided by National Institutes of Health Postdoctoral Fellowship F32 CA84757 (to K. E. B.), Gaining Assistance in Areas of National Need Grant 037733 (to H. L. H.), and NIGMS National Institutes of Health Training Grant GM07767 (to H. L. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Regeneron Pharmaceuticals, Tarrytown, NY 10591-6707.
To whom correspondence should be addressed: Dept. of Chemistry, University of Michigan, 930 N. University Ave., Ann Arbor, MI 48109-1055. Tel.: 734-936-2678; Fax: 734-647-4865; E-mail: fierke{at}umich.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Hast and L. S. Beese
Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid Substrate
J. Biol. Chem.,
November 14, 2008;
283(46):
31933 - 31940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Lane and L. S. Beese
Thematic review series: Lipid Posttranslational Modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I
J. Lipid Res.,
April 1, 2006;
47(4):
681 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|